×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Worldwide schedules comment Share
27545 views
Abbott is pleased to announce the Lunch Symposium organised for the first edition of CLIC (Critical Limb Ischemia Course) in Venice, on March 23th and 24th, 2017.
 
The symposium will be focused on clinical evidences for innovative endovascular techniques to treat femoro-popliteal and BTK obstructions, with the contribution of international experts from Australia, Europe and USA.
 

Chairman: Dr. Roberto Ferraresi (Milano, Italy)

Experts:

  • Dr. Larry Diaz (Wyoming, USA)
  • Prof. Yann Gouëffic (Nantes, France)
  • Prof. Pierfrancesco Veroux (Catania, Italy)
  • Dr. Shannon D. Thomas (Randwick, Australia)
     

Program

  • The presto technique for precise placement of the Supera in the SFA ostium and Supersub update
    Dr. Larry Diaz
     
  • CFA Stenting experiences
    Prof. Yann Gouëffic
     
  • Everolimus - Eluting stents for patients with CLI and infrapopliteal disease - The Etna registry
    Prof. Pierfrancesco Veroux (Catania, Italy)
     
  • 24 months results from ABSORB BTK Trial
    Dr. Shannon D. Thomas (Randwick, Australia)

Audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists).
     
  • Referring physicians of patients with peripheral artery disease.
Shooting date : 2017-03-24
Last update : 2017-04-13

CLIC 2017 : live cases

Edito The endovascular treatment of critical limb ischemia (CLI) and diabetic foot has become an important and promising approach for revasculariza...

Share
6 comments
Join the Discussion
See previous comments (1)
  • Roberto R. 1

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Vittorio R. Hello,
      For the long segment CTO in the fem/pop, can one substitute a Viabahn for the Supera Stent?

      • Larry D. Check the "Supersub" trial in Catheterization & Cardiovascular Interventions, November 2016.
        The answer is Yes, specially if crossing is achieved in subintimal fashion.

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Vittorio R. Hello,
      For long segment CTO of fem/pop, can one substitute Viabahn stent in place of Supera Stent, after recanalization in the subintimal space.

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      • khalid S. Please what is the role of tack stent in PTK lesions

          Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
          Your browser doesn't have Flash, Silverlight or HTML5 support.


        • mikeladze M. yes

            Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
            Your browser doesn't have Flash, Silverlight or HTML5 support.


          Suggestions

          December 2016
          Honolulu : Tuesday, December 13th 2016 from 12am to 01:45am (GMT-10)
          San Francisco : Tuesday, December 13th 2016 from 02am to 03:45am (GMT-8)
          New York : Tuesday, December 13th 2016 from 05am to 06:45am (GMT-5)
          Buenos Aires : Tuesday, December 13th 2016 from 07am to 08:45am (GMT-3)
          London / Dublin : Tuesday, December 13th 2016 from 10am to 11:45am (GMT)
          Paris / Berlin : Tuesday, December 13th 2016 from 11am to 12:45pm (GMT+1)
          Istanbul : Tuesday, December 13th 2016 from 12pm to 01:45pm (GMT+2)
          Moscou / Dubaï : Tuesday, December 13th 2016 from 02pm to 03:45pm (GMT+4)
          Bangkok : Tuesday, December 13th 2016 from 05pm to 06:45pm (GMT+7)
          Shanghai : Tuesday, December 13th 2016 from 06pm to 07:45pm (GMT+8)
          Tokyo : Tuesday, December 13th 2016 from 07pm to 08:45pm (GMT+9)
          Sydney : Tuesday, December 13th 2016 from 08pm to 09:45pm (GMT+10)
          Wellington : Tuesday, December 13th 2016 from 10pm to 11:45pm (GMT+12)

          3rd live Websymposium on Venous Interventions

          Learn and debate with the experts

          Share
          May 2012
          Honolulu : Thursday, May 24th 2012 from 04:59am to 07:13am (GMT-10)
          San Francisco : Thursday, May 24th 2012 from 07:59am to 10:13am (GMT-7)
          New York : Thursday, May 24th 2012 from 10:59am to 01:13pm (GMT-4)
          Buenos Aires : Thursday, May 24th 2012 from 11:59am to 02:13pm (GMT-3)
          Reykjavik : Thursday, May 24th 2012 from 02:59pm to 05:13pm (GMT)
          London / Dublin : Thursday, May 24th 2012 from 03:59pm to 06:13pm (GMT+1)
          Paris / Berlin : Thursday, May 24th 2012 from 04:59pm to 07:13pm (GMT+2)
          Istanbul : Thursday, May 24th 2012 from 05:59pm to 08:13pm (GMT+3)
          Moscou / Dubaï : Thursday, May 24th 2012 from 06:59pm to 09:13pm (GMT+4)
          Bangkok : Thursday, May 24th 2012 from 09:59pm to 12:13am (GMT+7)
          Shanghai : Thursday, May 24th 2012 from 10:59pm to 01:13am (GMT+8)
          Tokyo : Thursday, May 24th 2012 from 11:59pm to 02:13am (GMT+9)
          Sydney : Friday, May 25th 2012 from 01:59am to 04:13am (GMT+11)
          Wellington : Friday, May 25th 2012 from 03:59am to 06:13am (GMT+13)

          Discover the difference drug elution makes in the SFA with Zilver PTX stents:

          Max Amor, Flavio Airoldi ,Peter Gaines, William Kai,Jorg Tessarek

          Share
          Friday, February 23rd 2024 from 11am to 12:30pm (GMT+2)
          Honolulu : Thursday, February 22nd 2024 from 11pm to 12:30am (GMT-10)
          San Francisco : Friday, February 23rd 2024 from 01am to 02:30am (GMT-8)
          New York : Friday, February 23rd 2024 from 04am to 05:30am (GMT-5)
          Buenos Aires : Friday, February 23rd 2024 from 06am to 07:30am (GMT-3)
          London / Dublin : Friday, February 23rd 2024 from 09am to 10:30am (GMT)
          Paris / Berlin : Friday, February 23rd 2024 from 10am to 11:30am (GMT+1)
          Istanbul : Friday, February 23rd 2024 from 11am to 12:30pm (GMT+2)
          Moscou / Dubaï : Friday, February 23rd 2024 from 01pm to 02:30pm (GMT+4)
          Bangkok : Friday, February 23rd 2024 from 04pm to 05:30pm (GMT+7)
          Shanghai : Friday, February 23rd 2024 from 05pm to 06:30pm (GMT+8)
          Tokyo : Friday, February 23rd 2024 from 06pm to 07:30pm (GMT+9)
          Sydney : Friday, February 23rd 2024 from 07pm to 08:30pm (GMT+10)
          Wellington : Friday, February 23rd 2024 from 09pm to 10:30pm (GMT+12)

          Realizing the PAD Workflow of the Future

          A more efficient and Versatile Approach to Complex Lesions

          Share
          Thursday, October 28th 2021 from 06pm to 07pm (GMT+2)
          Honolulu : Thursday, October 28th 2021 from 06am to 07am (GMT-10)
          San Francisco : Thursday, October 28th 2021 from 09am to 10am (GMT-7)
          New York : Thursday, October 28th 2021 from 12pm to 01pm (GMT-4)
          Buenos Aires : Thursday, October 28th 2021 from 01pm to 02pm (GMT-3)
          Reykjavik : Thursday, October 28th 2021 from 04pm to 05pm (GMT)
          London / Dublin : Thursday, October 28th 2021 from 05pm to 06pm (GMT+1)
          Paris / Berlin : Thursday, October 28th 2021 from 06pm to 07pm (GMT+2)
          Istanbul : Thursday, October 28th 2021 from 07pm to 08pm (GMT+3)
          Moscou / Dubaï : Thursday, October 28th 2021 from 08pm to 09pm (GMT+4)
          Bangkok : Thursday, October 28th 2021 from 11pm to 12am (GMT+7)
          Shanghai : Friday, October 29th 2021 from 12am to 01am (GMT+8)
          Tokyo : Friday, October 29th 2021 from 01am to 02am (GMT+9)
          Sydney : Friday, October 29th 2021 from 03am to 04am (GMT+11)
          Wellington : Friday, October 29th 2021 from 05am to 06am (GMT+13)

          Strategies for Successful Management of Complex Long Lesions

          Share
          Thursday, November 4th 2021 from 05pm to 06:15pm (GMT+2)
          Honolulu : Thursday, November 4th 2021 from 05am to 06:15am (GMT-10)
          San Francisco : Thursday, November 4th 2021 from 07am to 08:15am (GMT-8)
          New York : Thursday, November 4th 2021 from 10am to 11:15am (GMT-5)
          Buenos Aires : Thursday, November 4th 2021 from 12pm to 01:15pm (GMT-3)
          London / Dublin : Thursday, November 4th 2021 from 03pm to 04:15pm (GMT)
          Paris / Berlin : Thursday, November 4th 2021 from 04pm to 05:15pm (GMT+1)
          Istanbul : Thursday, November 4th 2021 from 05pm to 06:15pm (GMT+2)
          Moscou / Dubaï : Thursday, November 4th 2021 from 07pm to 08:15pm (GMT+4)
          Bangkok : Thursday, November 4th 2021 from 10pm to 11:15pm (GMT+7)
          Shanghai : Thursday, November 4th 2021 from 11pm to 12:15am (GMT+8)
          Tokyo : Friday, November 5th 2021 from 12am to 01:15am (GMT+9)
          Sydney : Friday, November 5th 2021 from 01am to 02:15am (GMT+10)
          Wellington : Friday, November 5th 2021 from 03am to 04:15am (GMT+12)

          Challenges of fempop interventions – Crossing of complex lesions and preventing restenosis

          Swirling Flow: a replacement for anti-proliferative coating?

          Share
          Scroll Up